# Unique endoscopic features of primary biliary diffuse large B‐cell lymphoma: A case report with literature review (with video)

**Authors:** Tomoya Nakamura, Yoshiharu Masaki, Naohiro Kameyama, Yujiro Kawakami, Keisuke Ishigami, Yumemi Takada, Shuji Satoh, Taro Sugawara, Shintaro Sugita, Hiroshi Nakase

PMC · DOI: 10.1002/deo2.414 · DEN Open · 2024-07-28

## TL;DR

A 67-year-old man was diagnosed with a rare bile duct lymphoma using endoscopic techniques and biopsies, leading to successful treatment.

## Contribution

Highlights unique endoscopic features and diagnostic approach for primary biliary diffuse large B-cell lymphoma.

## Key findings

- Endoscopic ultrasonography showed irregular thickening of the bile duct without disappearance of the innermost layer.
- Repeated biopsies confirmed diffuse large B-cell lymphoma in the bile duct.
- Systemic chemotherapy led to significant improvement in bile duct stricture and lymphoma symptoms.

## Abstract

A 67‐year‐old man visited our hospital complaining of dark‐colored urine and upper abdominal pain. Magnetic resonance cholangiopancreatography showed stricture of the distal bile duct, and contrast‐enhanced computed tomography showed irregular thickening of the distal bile duct wall. However, no enlarged lymph nodes, pancreatic tumors, or other neoplastic lesions were apparent around the bile duct. Endoscopic ultrasonography and intraductal ultrasonography showed irregular thickening of the inner hypoechoic layer without the disappearance of the innermost thin hyperechoic layer. On the basis of these findings, we considered that the bile duct lesion was of non‐epithelial origin. Thus, we repeatedly performed bile duct biopsies from the same site under fluoroscopy to obtain a sample of the submucosal tissue. The pathological diagnosis was diffuse large B‐cell lymphoma, and the patient received systemic chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). After six courses of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, positron emission tomography‐computed tomography showed the disappearance of 18‐fluorodeoxyglucose uptake in the bile duct and endoscopic retrograde cholangiography showed improvement of the bile duct stricture. Endoscopic findings and repeated biopsies were useful in making the diagnosis of primary biliary diffuse large B‐cell lymphoma.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), doxorubicin (PubChem CID 31703), vincristine (PubChem CID 5978), prednisone (PubChem CID 5865)
- **Diseases:** diffuse large B-cell lymphoma (MONDO:0018905)

## Full-text entities

- **Diseases:** bile duct lesion (MESH:D001649), abdominal pain (MESH:D015746), neoplastic lesions (MESH:D009062), stricture of the (MESH:D003251), diffuse large B-cell lymphoma (MESH:D016403), pancreatic tumors (MESH:D010190)
- **Chemicals:** 18-fluorodeoxyglucose (-), rituximab (MESH:D000069283)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11284119/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11284119/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11284119/full.md

---
Source: https://tomesphere.com/paper/PMC11284119